Skip to content
MashupMD

MashupMD

Up-to-date medical news aggregated from trusted medical associations, journals, physicians and news outlets from around the world.

Navbar
  • Home
  • Features
  • Pricing
  • Disabled

Pembrolizumab Effective, Produces Durable Responses Over 3 Years in MSI-H mCRC

Posted on July 23, 2020 by Mashup MD

Pembrolizumab Effective, Produces Durable Responses Over 3 Years in MSI-H mCRC

Posted in Hem/Onc News and Journals, Latest HeadlinesTagged cancer

Post navigation

Previous: Tapping into Quantum Computing to Study Genetic Diseases
Next: Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
TESTING Proudly powered by WordPress | Theme: mashupmd by Underscores.me.